Metabolic abnormalities in growth hormone deficiency

Revista Argentina de Endocrinologia y Metabolismo

Volumn 45, Issue 5, 2008, Pages 214-223

  Lanes, Roberto ^a  

^a Hospital de Clinicas Caracas   (Venezuela)

Author keywords

Cardiac mass and function; Growth hormone deficiency; Intima media thickness and vascular reactivity; Lipoprotein abnormalities; Metabolic abnormalities; Visceral adiposity

Indexed keywords

ADIPONECTIN; BLOOD CLOTTING FACTOR; GROWTH HORMONE; HOMOCYSTEINE; PLACEBO;

ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEART PERFORMANCE; HORMONAL THERAPY; HUMAN; HYPOPITUITARISM; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; LONG TERM CARE; METABOLIC DISORDER; REVIEW; RISK FACTOR; STROKE;

EID: 57749118732     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Holmer H, Svensson J, Rylander L, Johannsson G, Rosen T, Bengtsson BA, Thoren M, Hoybye C, Degerblad M, Bramnert M, Hagg E, Engstrom BE, Ekman B, Norrving B, Hagmar L, Erfurth EM. 2007 Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab 92:3560-3567
2. Hagmar L, Erfurth EM. 2007 Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab 92:3560-3567
3. Bengtsson BA, Christiansen JS, Cuneo RC, Sacca L. 1997 Cardiovascular effects of GH. J Endocrinol 152:1-3
4. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. 1997 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195-200
5. Hoffman A, Kuntze J, Baptista J, Baum HB, Baumann G, Biller B, Clark R, Cook D, Inzucchi S, Kleinberg D, Klibanski A, Phillips L, Ridgway E, Robbins R, Schechte J, Sharma M, Thorner M, Vance M. 2004 Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2048-2056
6. Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P. 2004 Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89: 2192-2199
7. Koranyi J, Gothesrstrom G, Sunnerhagen KS, Bengtsson B, Johansson G. 2001 Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab 86:4693-4699
8. Kuromaru R, Kohno H, Ueyama N, Hassan H, Hara T. 1998 Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab 83:3890-3896
9. Johannsson G, Albertsson-Wikland K. 1999 Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-suficient adolescent patients compared with control subjects. J Clin Endocrinol Metab 84:4516-4524
10. Carroll P, Drake W, Maher K, Metcalfe M, Shaw N, Dunger D, Cheetham T, Camacho- Hubner C, Savage M, Monson J. 2004 Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J Clin Endocrinol Metab 89;3890-3895
11. Svensson J, Sunnerhagen K, Johannsson G. 2003 Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. J Clin Endocrinol Metab 88:2061-2069
12. Ter Maaten J, De Boer H, Kamp O, Stuurman L, Van Der Veen E. 1999 Long term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 84:2373-2380
13. Murray R, Wieringat G, Lissett C, Darzy K, Smethurst L, Shalet S. 2002 Low dose replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clin Endocrinol 56:525-532
14. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. 2001 Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 86:1874-1881
15. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R. 2001 Cardiac mass and function, carotid artery intima-media thickness and lipoprotein levels in growth hormone deficient adolescents. J Clin Endocrinol Metab 86:1061-65.91
16. Lanes R, Paoli M, Carrillo E , Villaroel O, Palacios A. 2003 The Cardiovascular risk of young growth hormone deficient adolescents; differences in growth hormone treated and untreated subjects. Hormone Research 60:291-295
17. Al-Shoumer K, Cox K, Hughes C, Richmond, Johnston D. 1997 Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab 82:2653-2659
18. Twickler T, Wilmink H, Schreuder N, Casto Cabezas M, van Dam P, Koppeschaar D, Erkelens D, Dallinga-Thie G. 2000 Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. J Clin Endocrinol Metab 85:4683-4689
19. Twickler T, Dallinga-Thie G, Visseren F, de Vries W, Erkelens D, Koppershaar H. 2003 Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle cholesterol concentration. J Clin Endocrinol Metab 88:1228-1232
20. Oliveira J, Aguiar-Oliveira M, D'Oliveira A, Pereira R, Oliveira C, Farias C, Barreto-Filho J, Anjos-Andrade F, Marques-Santos C, Nascimento-Junior A, Alves E, Oliveira F, Campos V, Ximenes R, Blackford A, Parmigiani G, Salvator R. 2007 Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naïve adults. J Clin Endocrinol Metab 92:4664-4670
21. Capaldo B, Patti L, Oliviero U, et al. 1997 Increased arterial intima-media thickness in childhood onset growth hormone deficiency. J Clin Endocrinol Metab 82:1378-1381
22. Johansson J, Landin K, Tengborn L, Rosen T, Bengsson B. 1994 High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arteroscler Thromb 14:434-437
23. Wilhemsen L. Svardsudd K, Korsan-Bengtsen K, Larsson B, Weiin L, Tibblin G. 1984 Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501-505
24. Hamsten A, deFaire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. 1987 Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2: 3-9
25. Evans L, Davies J, Anderson R, Jackson S, Smith J, Morgan C, McDowell I, Rees A, ScanIon M. 1999 Elevated plasma homocysteine levels are associated with enhanced oxidative stress and endothelial dysfunction in adult hypopituitary patients with growth hormone deficiency. J Endocrinol 160:(Suppl.),22
26. Sesmilo G, Biller B, Llevado J, Hayden D, Hanson G, Rifai N, Klibanski A. 2001 Effects of growth hormone (GH) administration on homocysteine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab 86:1518-1524
27. Abdu T, Elhadd T, Akber M, Hartland A, Neary R, Clayton N. 2001 Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults. Clin Endocrinol 55:635-638
28. Thum T, Fleissner F, Klink I, Tsikas D, Jakob M, Bauersachs J, Stichtenoth D. 2007 Growth hormone treatment improves markers of systemic nitric oxide bioavailablity via insulin-like growth factor-1. J Clin Endocrinol Metab 92:4172-4179
29. Li G, del Rincon J, Jahn L, Wu Y, Gaylinn B, Thorner M, Liu Z. 2008 Growth hormone exerts acute vascular effects independent of systemic or muscle inslulin-like growth factor-1. J Clin Endocrinol Metab 93:1379-1385
30. Leonsson M, Hulthe J, Johannsson G, Wiklund O, Wikstrandt J, Bengtsson B, Oscarsson J. 2003 Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clinical Endocrinology 59:242-250
31. Lanes R, Paoli M, Carrillo E, Villaroel O, Palacios A. 2004 Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency. Relation to postprandial dyslipidemia. J Pediatr 45:659-653.13
32. Lanes R, Marcano H, Villaroel O, Moriilo E, Gunczler P, Paoli M, Perez M, Maulino N, Palacios A. 2008 Circulating levels of highly sensitive C-reactive protein and soluble markers of vascular cell activation in growth hormone deficiency. Horm Res 70:230-235
33. Elhadd T, Abdu T, Oxtoby J, Kennedy G, McLaren M, Neary R, Belch J, Clayton R. 2001 Biochemical and biophysical markers of endothelial dysfuction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab 86: 4223-4232
34. Pilz S, Horejsi R, Moller R, Almer G, Schar nagl H, Stojakovic T, Dimitrova R, Weihrauch G, Borkenstein M, Maerz W, Schauenstein K, Mangge H. 2005 Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 90:4792-4796
35. Eden Engstrom B, Burman P, Holdstock C, Karlsson F. 2003 Effects of growth hormone (GH) on ghrelin, leptin and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 88:5193-5198
36. Hana V, Silha J, Justova V, Lacinova Z,Stepan J, Murphy I. 2004 The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitanmt changes in adipokines and insulin resistance. Clin Endocrinol (Oxf) 60:442-450
37. Lanes R, Soros A, Gunczler P, Paoli M, Carrillo E, Villaroel O, Palacios A. 2006 Growth hormone deficiency in adolescence is associated with low serum levels of adiponectin and with an unfavorable serum lipid and lipoprotein profile. J Pediatr 149:324-329
38. Longobardi S, Cuocolo A, Merola B, et al. 1998 Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol 48:137-143
39. Vacaldi R, Gaddi O, Zini M, et al. Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment. J Clin Endocrinol Metab 86:659-666
40. Colao A, Di Somma C, Salerno MC, Spinelli L, Orio F y Lombardi G. 2002 The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 87: 3650-3655.
41. Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, Tanfurri de Horatio L, Lombardi G and Coalo A. 2004 Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol 60: 630-636.
42. Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R and Boucek RJ. 2003 Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 88: 4095-4199.318.
43. Lanes R, Soros A, Flores K, Gunczler P, Carrillo E and Bandel J. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue and left ventricular mass and function in growth hormone deficient adolescents. J Clin Endocrinol Metab 90: 3978-3982; 2005.
44. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y y Berthezene F. 1999 Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 84:1329-1333.
45. Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF y Davies JS. 2002 Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults; a randomized, double-blind, palcebo-controlled study. Clin Endocrinol 5:493-501.
46. Husbands S, Ong K, Gilbert J, Wass J, Dunger D. 2001 Increased insulin sensitivity in young, growth hormone deficient children. Clin Endocrinol 55:87-92
47. Bramnert M, Segerlantz M, Luarila E, Daugaard JR, Manhe P, Groop L. 2003 Growth hormone replacement therapy induces insulin resitance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 1455-1463